FDA approves updated covid vaccines, but with severe new limits
On Wednesday, the FDA approved a new round of COVID-19 vaccines developed by Pfizer, Moderna, and Novavax for seniors aged 65 and older. The approval for younger individuals is limited to those who have at least one underlying condition that increases their risk of severe outcomes from COVID-19. Additionally, the FDA has revoked emergency use […]
FDA approves updated covid vaccines, but with severe new limits Read More »










